Evidence map›Paper›PMID 36414658›Full record

ArticleNature communications2022

Leveraging data-driven self-consistency for high-fidelity gene expression recovery.

Md Tauhidul Islam, Jen-Yeu Wang, Hongyi Ren, Xiaomeng Li, Masoud Badiei Khuzani, Shengtian Sang, Lequan Yu, Liyue Shen, Wei Zhao, Lei Xing

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Artificial Intelligence Revolution in Transcriptomics: From Single Cells to Spatial Atlases.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Bladder Cancer and Artificial Intelligence: Emerging Applications.The Urologic clinics of North America · 2024
    Review
  3. Article
  4. Article
  5. [Imputation method for dropout in single-cell transcriptome data].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2023
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Md Tauhidul IslamDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0001-6259-632X
Jen-Yeu WangDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Hongyi RenDepartment of Electrical Engineering, Stanford University, Stanford, CA, 94305, USA.ORCID 0000-0001-6999-0370
Xiaomeng LiDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Masoud Badiei KhuzaniDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Shengtian SangDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Lequan YuDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Liyue ShenDepartment of Electrical Engineering, Stanford University, Stanford, CA, 94305, USA.
Wei ZhaoDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA.
Lei XingDepartment of Radiation Oncology, Stanford University, Stanford, CA, 94305, USA. lei@stanford.edu.ORCID 0000-0003-2536-5359

Funding

Dual Modality X-ray Luminescence CT for in vivo Cancer ImagingR01CA227713 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2019 to 2023
$2.9M
Radioluminescence dosimetry solution for precision radiation therapyR01CA223667 · NCI · STANFORD UNIVERSITY · PI XING, LEI · 2018 to 2022
$2.4M
NCI NIH HHS R01 CA223667NCI NIH HHS R01 CA227713
6 · The paper itself

Abstract

Single cell RNA sequencing is a promising technique to determine the states of individual cells and classify novel cell subtypes. In current sequence data analysis, however, genes with low expressions are omitted, which leads to inaccurate gene counts and hinders downstream analysis. Recovering these omitted expression values presents a challenge because of the large size of the data. Here, we introduce a data-driven gene expression recovery framework, referred to as self-consistent expression recovery machine (SERM), to impute the missing expressions. Using a neural network, the technique first learns the underlying data distribution from a subset of the noisy data. It then recovers the overall expression data by imposing a self-consistency on the expression matrix, thus ensuring that the expression levels are similarly distributed in different parts of the matrix. We show that SERM improves the accuracy of gene imputation with orders of magnitude enhancement in computational efficiency in comparison to the state-of-the-art imputation techniques.

Indexed as

Selective Estrogen Receptor ModulatorsGene ExpressionSelective Estrogen Receptor Modulators

Identifiers

PMID36414658
PMCPMC9681852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.